Proton vs Photon IMRT in Locally Advanced Nasopharyngeal Carcinoma: A Phase III Trial

NCT07340515 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Carcinoma (NPC)

Interventions

RADIATION: Intensity-Modulated Proton Therapy (IMPT)
RADIATION: Intensity-Modulated Radiation Therapy (IMRT)
DRUG: Cisplatin
BIOLOGICAL: Toripalimab

Sponsor

Man Hu

Collaborators

Shandong Cancer Hospital and Institute